View in EDS HTML Full Text PDF Full Text

Characterizing Cardiotoxicity of FDA-Approved Soft Tissue Sarcoma Targeted Therapies and Immune Checkpoint Inhibitors: A Systematic Review.

Saved in:
Bibliographic Details
Title: Characterizing Cardiotoxicity of FDA-Approved Soft Tissue Sarcoma Targeted Therapies and Immune Checkpoint Inhibitors: A Systematic Review.
Authors: Houmsse, Mustafa1 (AUTHOR), Muskara, Andrew1,2 (AUTHOR), Pasca, Damaris2,3 (AUTHOR), Roy, Arnab2,4 (AUTHOR), Sughra, Sana3,5 (AUTHOR), Ghazi, Sanam3 (AUTHOR), Addison, Daniel3,4 (AUTHOR) daniel.addison@osumc.edu, Husain, Marium5 (AUTHOR) marium.husain@osumc.edu
Source: Cancers. Mar2025, Vol. 17 Issue 5, p827. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers17050827